Hood River Capital Management LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1578177
PALM BEACH GARDENS, FL
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,206,024
+$20,799,385 QoQ
Shares Held
882,738
+6.4% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#21
of 343 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hood River Capital Management LLC holds $1,664,762,065 across 20 Biotechnology names. PTGX ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
663,375 | $246,556,586 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
425,167 | $142,341,659 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
1,738,613 | $141,818,662 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
2,224,788 | $122,363,340 | |
| 5 | INSM |
INSMED Inc
|
1,056,871 | $112,683,586 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
This page
|
882,738 | $108,206,024 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,347,535 | $100,364,406 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
402,678 | $98,563,494 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,206,024 | 882,738 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $87,406,639 | 829,285 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||